New eye drops aim to soothe dry eyes in clinical trial
NCT ID NCT04343287
First seen May 07, 2026 · Last updated May 07, 2026
Summary
This study tested whether BRM421 eye drops can safely reduce the signs and symptoms of dry eye compared to a placebo. A total of 220 adults with a history of dry eye for at least 6 months participated. The main focus was on changes in corneal staining and patient-reported dryness after 14 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Andover Eye Associates
Andover, Massachusetts, 01810, United States
-
Eye Research Foundation
Newport Beach, California, 92663, United States
-
Midwest Cornea Associates, LLC
Indianapolis, Indiana, 46290, United States
-
Total Eye Care
Memphis, Tennessee, 38119, United States
Conditions
Explore the condition pages connected to this study.